[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100519486":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":27,"locations":37,"responsibleParty":55,"collaborators":32,"id":58,"slug":32,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":32,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":40,"whyStopped":32,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention group","EXPERIMENTAL","Receive leucine on a daily basis for 10 weeks.",[13],"Dietary Supplement: Dietary Supplement: Leucine",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DIETARY_SUPPLEMENT","Dietary Supplement: Leucine","150mg\u002Fkg body mass\u002Fday",[9],[21],"Amino Acid",[23],{"name":24,"affiliation":25,"role":26},"Kaat Desloovere, Prof. dr.","Department of Rehabilitation Sciences, KU Leuven, Belgium","PRINCIPAL_INVESTIGATOR",[28,34],{"name":29,"role":30,"phone":31,"phoneExt":32,"email":33},"Ineke Verreydt","CONTACT","+3216341016",null,"ineke.verreydt@kuleuven.be",{"name":35,"role":30,"phone":32,"phoneExt":32,"email":36},"Lauraine Staut","lauraine.staut@kuleuven.be",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"UZ Leuven","RECRUITING","Leuven","Vlaams-Brabant","3000","Belgium",{"type":46,"coordinates":47},"Point",[48,49],4.70093,50.87959,{"lat":49,"lon":48},[52],{"name":24,"role":30,"phone":53,"phoneExt":32,"email":54},"+3216338009","kaat.desloovere@uzleuven.be",{"type":26,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":32,"oldOrganization":32},"Kaat Desloovere","Prof. dr.","100519486",false,"NCT06044168","Feasibility Nutritional Supplements for Muscle Growth in CP","Feasibility Study: Nutritional Supplements to Support Muscle Growth in Children With Cerebral Palsy","Nut-CP","Inclusion Criteria:\n\nSpastic Cerebral Palsy (diagnosed by a neuro-pediatrician from the CP Reference Centre of the University Hospital Leuven)\n\n* Uni- of bilateral involvement\n* Level II or III on the Gross Motor Function Classification System (GMFCS)\n* Muscle volume for the medial gastrocnemius (target muscle) of at least 20% compared to the expected muscle volume in age-matched typically developing children\n\nExclusion Criteria:\n\n* Presence of dyskinesia or ataxia\n* Severe co-morbidities\n* Botulinum toxin treatment ten months prior to assessment\n* Previous orthopedic or neurosurgery\n* Severe ankle deformities preventing fitting in test positions\n* Ankle range of motion (ROM) \\\u003C30% of normal values","ALL","4 Years","10 Years",{"count":69,"type":70},5,"ESTIMATED","INTERVENTIONAL",[73],"NA","The purpose of this study is to investigate the feasibility of a 10-week plan with a nutritional supplement (leucine) and to perform pilot analyses on the effect of leucine on macroscopic muscle morphology in children with cerebral palsy.",[76],"Spastic Cerebral Palsy",[76,78,79,80,81,82],"3D freehand ultrasound","Muscle morphology","Nutritional supplements","Leucine","Feasibility","2026-05-04",{"date":85,"type":86},"2026-05-05","ACTUAL",{"date":88,"type":86},"2023-07-31",{"date":90,"type":70},"2027-12",{"name":5,"class":6},1]